雷诺氏病
Raynaud's disease.
作者信息
Burns E C, Dunger D B, Dillon M J
出版信息
Arch Dis Child. 1985 Jun;60(6):537-41. doi: 10.1136/adc.60.6.537.
Abstract
We report five children who presented with Raynaud's disease in whom we could find no clinical, haematological, or immunological evidence of a collagen disorder. Oral phenoxybenzamine proved useful for maintenance treatment in most, with infusions of prostacyclin, nitroprusside, and ketanserin during acute attacks.
摘要
我们报告了5名患有雷诺病的儿童，在他们身上我们未发现任何胶原紊乱的临床、血液学或免疫学证据。口服酚苄明对大多数患儿的维持治疗有效，急性发作时可输注前列环素、硝普钠和酮色林。
相似文献
1
Raynaud's disease.雷诺氏病
Arch Dis Child. 1985 Jun;60(6):537-41. doi: 10.1136/adc.60.6.537.
2
Treatment of childhood Raynaud's disease by transdermal prostaglandin E2 analogue.
Lancet. 1985 Jul 6;2(8445):50. doi: 10.1016/s0140-6736(85)90108-4.
3
Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.静脉输注伊洛前列素与口服硝苯地平治疗系统性硬化症患者雷诺现象的比较：一项双盲随机研究。
BMJ. 1989 Mar 4;298(6673):561-4. doi: 10.1136/bmj.298.6673.561.
4
New prospects for the treatment of Raynaud's phenomenon using a serotoninergic S2 receptor antagonist (ketanserin) and stable derivatives of prostacyclin.
Angiology. 1993 Feb;44(2):123-8. doi: 10.1177/000331979304400206.
5
Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.
Angiology. 1989 Feb;40(2):114-21. doi: 10.1177/000331978904000206.
6
Ketanserin versus nifedipine in secondary Raynaud's phenomenon.
Vasa. 1987;16(1):77-80.
7
Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin.使用5-羟色胺2受体拮抗剂酮色林治疗雷诺现象。
Br Med J (Clin Res Ed). 1982 Oct 16;285(6348):1069-71. doi: 10.1136/bmj.285.6348.1069.
8
Epoprostenol in patients with Raynaud's disease.
Prostaglandins Leukot Essent Fatty Acids. 1988 Jul;33(1):23-7. doi: 10.1016/0952-3278(88)90118-4.
9
Raynaud's disease and prostacyclin.
Ann Intern Med. 1983 Feb;98(2):258. doi: 10.7326/0003-4819-98-2-258_3.
10
Pharmacologic management of Raynaud's phenomenon.
South Med J. 1984 Sep;77(9):1160-4. doi: 10.1097/00007611-198409000-00027.
引用本文的文献
1
Acrocyanosis due to imipramine.因丙咪嗪所致的手足发绀症。
Arch Dis Child. 1988 Feb;63(2):204-5. doi: 10.1136/adc.63.2.204.
2
Management of Raynaud's phenomenon. Focus on newer treatments.雷诺现象的管理。聚焦于新型治疗方法。
Drugs. 1989 May;37(5):700-12. doi: 10.2165/00003495-198937050-00005.
本文引用的文献
1
Raynaud's disease; a study of criteria for prognosis.
Surgery. 1951 Mar;29(3):387-97.
2
Raynaud's disease among women and girls.
Circulation. 1957 Dec;16(6):1012-21. doi: 10.1161/01.cir.16.6.1012.
3
Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon.
J Rheumatol. 1982 Nov-Dec;9(6):878-84.
4
Prognostic significance of Raynaud's phenomenon in children.
Clin Pediatr (Phila). 1983 Jan;22(1):22-5. doi: 10.1177/000992288302200103.
5
Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis.
Clin Genet. 1980 Sep;18(3):191-6. doi: 10.1111/j.1399-0004.1980.tb00870.x.
6
Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.用酮色林治疗结缔组织病患者的雷诺现象。
Br Med J (Clin Res Ed). 1984 Sep 8;289(6445):577-9. doi: 10.1136/bmj.289.6445.577.
7
Systemic sclerosis--a microvascular disorder?系统性硬化症——一种微血管疾病？
J R Soc Med. 1983 Aug;76(8):635-42. doi: 10.1177/014107688307600804.
8
Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.硝苯地平治疗雷诺现象的对照双盲试验。
N Engl J Med. 1983 Apr 14;308(15):880-3. doi: 10.1056/NEJM198304143081507.
9
Raynaud's syndrome: current trends.
Br J Rheumatol. 1983 Feb;22(1):50-5. doi: 10.1093/rheumatology/22.1.50.
10
On the nature of Raynaud's phenomenon: the role of histamine.关于雷诺现象的本质：组胺的作用。
Lancet. 1983 Aug 6;2(8345):313-5. doi: 10.1016/s0140-6736(83)90292-1.
Zotero 插件